Cargando…

Plasma Metabolomics and Lipidomics Reveal Perturbed Metabolites in Different Disease Stages of Chronic Obstructive Pulmonary Disease

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common disease characterized by persistent respiratory symptoms and airflow restriction. It is usually manifested as airway and/or alveolar abnormalities caused by significant exposure to harmful particulates or gases. OBJECTIVE: We aim t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Juntuo, Li, Qiuyu, Liu, Chengyang, Pang, Ruifang, Yin, Yuxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073598/ https://www.ncbi.nlm.nih.gov/pubmed/32210549 http://dx.doi.org/10.2147/COPD.S229505

Ejemplares similares

Differentiation in TCM patterns of chronic obstructive pulmonary disease by comprehensive metabolomic and lipidomic characterization
por: Li, Jiansheng, et al.
Publicado: (2023)

Untargeted Plasma Lipidomics Reveal Perturbed Metabolites of Glycerophospholipids, and Sphingolipids in Moderate-to-Severe Acne
por: Zhang, Deng, et al.
Publicado: (2023)

Lipidomic analysis of serum samples from migraine patients
por: Ren, Caixia, et al.
Publicado: (2018)

Metabolic detection of malignant brain gliomas through plasma lipidomic analysis and support vector machine-based machine learning
por: Zhou, Juntuo, et al.
Publicado: (2022)

Plasma metabolomic and lipidomic alterations associated with COVID-19
por: Wu, Di, et al.
Publicado: (2020)

Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
por: Han, Xianlin, et al.
Publicado: (2011)

Integrative metabolome and lipidome analyses of plasma in neovascular macular degeneration
por: Zhao, Tantai, et al.
Publicado: (2023)

An Updated Overview of Metabolomic Profile Changes in Chronic Obstructive Pulmonary Disease
por: Ran, Nan, et al.
Publicado: (2019)

Plasma Metabolome and Lipidome Associations with Type 2 Diabetes and Diabetic Nephropathy
por: Tan, Yan Ming, et al.
Publicado: (2021)

Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
por: Beyoğlu, Diren, et al.
Publicado: (2020)

Perturbations of Lipid Metabolism Indexed by Lipidomic Biomarkers
por: Lamaziere, Antonin, et al.
Publicado: (2012)

Applications of liquid chromatography-mass spectrometry based metabolomics in predictive and personalized medicine
por: Zhou, Juntuo, et al.
Publicado: (2022)

Metabolomics analyses of serum metabolites perturbations associated with Naja atra bite
por: He, Dongling, et al.
Publicado: (2023)

Plasma Metabolomic Signatures of Chronic Obstructive Pulmonary Disease and the Impact of Genetic Variants on Phenotype-Driven Modules
por: Gillenwater, Lucas A., et al.
Publicado: (2020)

Effect of roxadustat on serum metabolome and lipidome in patients with end-stage renal disease and erythropoiesis-stimulating agent resistance
por: Wang, Lichao, et al.
Publicado: (2022)

Integrated Analysis of Metabolomics and Lipidomics in Plasma of T2DM Patients with Diabetic Retinopathy
por: Ding, Chun, et al.
Publicado: (2022)

A resource of lipidomics and metabolomics data from individuals with undiagnosed diseases
por: Kyle, Jennifer E., et al.
Publicado: (2021)

Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I
por: Mathis, Tamara, et al.
Publicado: (2021)

Metabolomes and Lipidomes of the Infective Stages of the Gastrointestinal nematodes, Nippostrongylus brasiliensis and Trichuris muris
por: Yeshi, Karma, et al.
Publicado: (2020)

Plasma Metabolomic and Lipidomic Profiling of Metabolic Dysfunction-Associated Fatty Liver Disease in Humans Using an Untargeted Multiplatform Approach
por: Lin, Xiangping, et al.
Publicado: (2022)

Plasma metabolomics, lipidomics and cytokinomics profiling predict disease recurrence in metastatic colorectal cancer patients undergoing liver resection
por: Costantini, Susan, et al.
Publicado: (2023)

Enantioselectivity Effects in Clinical Metabolomics and Lipidomics
por: Oliveira, Regina V., et al.
Publicado: (2021)

Plasma lipidome is dysregulated in Alzheimer’s disease and is associated with disease risk genes
por: Liu, Yue, et al.
Publicado: (2021)

Impact of Blood Collection Tubes and Sample Handling Time on Serum and Plasma Metabolome and Lipidome
por: Cruickshank-Quinn, Charmion, et al.
Publicado: (2018)

Metabolomic and lipidomic plasma profile changes in human participants ascending to Everest Base Camp
por: O’Brien, Katie A., et al.
Publicado: (2019)

Seminal plasma metabolomics and lipidomics profiling to identify signatures of pituitary stalk interruption syndrome
por: Guo, Ye, et al.
Publicado: (2022)

Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury
por: Wang, Ming-Gui, et al.
Publicado: (2022)

Untargeted metabolomic and lipidomic analyses reveal lipid dysregulation in the plasma of acute leukemia patients
por: Arévalo, Cindy, et al.
Publicado: (2023)

Metabolomic and lipidomic profile in men with obstructive sleep apnoea: implications for diagnosis and biomarkers of cardiovascular risk
por: Lebkuchen, Adriana, et al.
Publicado: (2018)

Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity
por: Lanzon, Borja, et al.
Publicado: (2021)

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer’s disease brains
por: Novotny, Brenna C., et al.
Publicado: (2023)

Plasma Lipidomics Approach in Early and Specific Alzheimer’s Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2022)

Defining the Baseline and Oxidant Perturbed Lipidomic Profiles of Daphnia magna
por: Taylor, Nadine S., et al.
Publicado: (2017)

Lipidomic Perturbations in Cynomolgus Monkeys are Regulated by Thyroid Stimulating Hormone
por: Xu, Tao, et al.
Publicado: (2021)

Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease
por: Dakterzada, Farida, et al.
Publicado: (2023)

Changes in targeted metabolomics in lung tissue of chronic obstructive pulmonary disease
por: Feng, Yi, et al.
Publicado: (2023)

Mapping the metabolomic and lipidomic changes in the bleomycin model of pulmonary fibrosis in young and aged mice
por: Weckerle, Jelena, et al.
Publicado: (2022)

Lipidomics unveils the complexity of the lipidome in metabolic diseases
por: Lydic, Todd A., et al.
Publicado: (2018)

Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease
por: Bowerman, Kate L., et al.
Publicado: (2020)

Targeted metabolomic analysis of plasma metabolites in patients with coronary heart disease in southern China
por: Zhong, Zhixiong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_puv2vk905e1t73c5tt7k5vbtbv